These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20054479)

  • 21. Proteasome inhibition activates the transport and the ectodomain shedding of TNF-alpha receptors in human endothelial cells.
    Peiretti F; Canault M; Bernot D; Bonardo B; Deprez-Beauclair P; Juhan-Vague I; Nalbone G
    J Cell Sci; 2005 Mar; 118(Pt 5):1061-70. PubMed ID: 15731011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TIMP-3 ameliorates hepatic ischemia/reperfusion injury through inhibition of tumor necrosis factor-alpha-converting enzyme activity in rats.
    Tang ZY; Loss G; Carmody I; Cohen AJ
    Transplantation; 2006 Dec; 82(11):1518-23. PubMed ID: 17164725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel methods and strategies in the discovery of TACE inhibitors.
    Murumkar PR; Giridhar R; Yadav MR
    Expert Opin Drug Discov; 2013 Feb; 8(2):157-81. PubMed ID: 23231541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of TNF-alpha converting enzyme and proteinase-3 to TNF-alpha processing in human alveolar macrophages.
    Armstrong L; Godinho SI; Uppington KM; Whittington HA; Millar AB
    Am J Respir Cell Mol Biol; 2006 Feb; 34(2):219-25. PubMed ID: 16210695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between the increase of secretion of sTNF alpha induced by lipopolysaccharides and the enhanced expression of TACE mRNA in HL-60 cells and adhesive cells from human spleen.
    Ding T; Li L; Zhu K; Huang W; Yang Y
    J Tongji Med Univ; 2001; 21(4):265-8, 279. PubMed ID: 12539543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The TNF alpha converting enzyme (TACE/ADAM17) is expressed in the atherosclerotic lesions of apolipoprotein E-deficient mice: possible contribution to elevated plasma levels of soluble TNF alpha receptors.
    Canault M; Peiretti F; Kopp F; Bonardo B; Bonzi MF; Coudeyre JC; Alessi MC; Juhan-Vague I; Nalbone G
    Atherosclerosis; 2006 Jul; 187(1):82-91. PubMed ID: 16214147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of TNF-alpha-converting enzyme-ectodomain shedding by pathogenic autoantibodies.
    Sisto M; Lisi S; Lofrumento DD; Frassanito MA; Cucci L; D'Amore S; Mitolo V; D'Amore M
    Int Immunol; 2009 Dec; 21(12):1341-9. PubMed ID: 19854762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and protein chemistry yielding crystallization of the catalytic domain of ADAM17 complexed with a hydroxamate inhibitor.
    Hoth LR; Tan DH; Wang IK; Wengender PA; Thompson MA; Kamath AV; Geoghegan KF
    Protein Expr Purif; 2007 Apr; 52(2):313-9. PubMed ID: 17169570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A role for cGMP in inducible nitric-oxide synthase (iNOS)-induced tumor necrosis factor (TNF) α-converting enzyme (TACE/ADAM17) activation, translocation, and TNF receptor 1 (TNFR1) shedding in hepatocytes.
    Chanthaphavong RS; Loughran PA; Lee TY; Scott MJ; Billiar TR
    J Biol Chem; 2012 Oct; 287(43):35887-98. PubMed ID: 22898814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ceramide kinase regulates the production of tumor necrosis factor α (TNFα) via inhibition of TNFα-converting enzyme.
    Lamour NF; Wijesinghe DS; Mietla JA; Ward KE; Stahelin RV; Chalfant CE
    J Biol Chem; 2011 Dec; 286(50):42808-17. PubMed ID: 22009748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-based rational design of peptide hydroxamic acid inhibitors to target tumor necrosis factor-α converting enzyme as potential therapeutics for hepatitis.
    Wu D; Gu Q; Zhao N; Xia F; Li Z
    J Drug Target; 2015 Dec; 23(10):936-42. PubMed ID: 26061299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of the role of TNF-α converting enzyme (TACE) in the inhibition of cell surface and soluble TNF-α production by acute ethanol exposure.
    von Maltzan K; Tan W; Pruett SB
    PLoS One; 2012; 7(2):e29890. PubMed ID: 22319556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reactive site mutations in tissue inhibitor of metalloproteinase-3 disrupt inhibition of matrix metalloproteinases but not tumor necrosis factor-alpha-converting enzyme.
    Wei S; Kashiwagi M; Kota S; Xie Z; Nagase H; Brew K
    J Biol Chem; 2005 Sep; 280(38):32877-82. PubMed ID: 16079149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of reduqing on HL-60 cells in secreting tumor necrosis factor alpha production and on TNF alpha converting enzyme mRNA expression].
    Wang KF; Li MZ; Yang YZ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Apr; 21(4):283-5. PubMed ID: 12577359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor necrosis factor-α converting enzyme is a key mediator of abdominal aortic aneurysm development.
    Kaneko H; Anzai T; Horiuchi K; Kohno T; Nagai T; Anzai A; Takahashi T; Sasaki A; Shimoda M; Maekawa Y; Shimizu H; Yoshikawa T; Okada Y; Yozu R; Fukuda K
    Atherosclerosis; 2011 Oct; 218(2):470-8. PubMed ID: 21722904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.
    Huang A; Joseph-McCarthy D; Lovering F; Sun L; Wang W; Xu W; Zhu Y; Cui J; Zhang Y; Levin JI
    Bioorg Med Chem; 2007 Sep; 15(18):6170-81. PubMed ID: 17606376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of tumor necrosis factor receptor 1 and TNF-alpha converting enzyme during corneal wound healing.
    Sakimoto T; Yamada A; Kanno H; Sawa M
    Jpn J Ophthalmol; 2008; 52(5):393-398. PubMed ID: 18991041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alcohol Decreases Organic Dust-Stimulated Airway Epithelial TNF-Alpha Through a Nitric Oxide and Protein Kinase-Mediated Inhibition of TACE.
    Gerald CL; Romberger DJ; DeVasure JM; Khazanchi R; Nordgren TM; Heires AJ; Sisson JH; Wyatt TA
    Alcohol Clin Exp Res; 2016 Feb; 40(2):273-83. PubMed ID: 26842246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TNF blocker drugs modulate human TNF-α-converting enzyme pro-domain shedding induced by autoantibodies.
    Sisto M; Lisi S; Lofrumento DD; Caprio S; Mitolo V; D'Amore M
    Immunobiology; 2010 Nov; 215(11):874-83. PubMed ID: 20061048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple shRNA-mediated knockdown of TACE reduces the malignancy of HeLa cells.
    Yan Y; Zhang J; Guo JL; Huang W; Yang YZ
    Cell Biol Int; 2009 Feb; 33(2):158-64. PubMed ID: 18996214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.